Yu-fu Zhou

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration.

Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: March 05, 2024

Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation.

Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation.

Journal: Hepatology international

Published: December 02, 2022

CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor.

CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor.

Journal: Cell discovery

Published: November 17, 2022

Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis.

Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis.

Journal: Journal for immunotherapy of cancer

Published: July 08, 2021

Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection.

Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection.

Journal: Annals of translational medicine

Published: May 13, 2020

Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.

Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.

Journal: BMC cancer

Published: February 23, 2020

Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection.

Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection.

Journal: British journal of cancer

Published: February 17, 2020

Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study.

Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study.

Journal: Aging

Published: August 25, 2019

Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma.

Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma.

Journal: BMC medicine

Published: December 06, 2018

Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma.

Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma.

Journal: Cancer management and research

Published: November 26, 2018

Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomy.

Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomy.

Journal: Cancer immunology, immunotherapy : CII

Published: September 21, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026